Search
Search Results
-
Higher HbA1c variability is associated with increased arterial stiffness in individuals with type 1 diabetes
BackgroundBoth long-term glycaemic variability and arterial stiffness have been recognized as cardiovascular risk factors. This study aims to...
-
High-performance liquid chromatography local reference ranges of hemoglobin fractions (HbA, HbA2, and HbF) in detection of hemoglobinopathies in western Kenya
BackgroundWestern Kenya, being a malaria-endemic region, has a high prevalence of hemoglobinopathies mostly sickle cell and thalassemia. The...
-
Predicting the HbA1c level following glucose-lowering interventions in individuals with HbA1c-defined prediabetes: a post-hoc analysis from the randomized controlled PRE-D trial
PurposeTo investigate whether the prediction of post-treatment HbA 1c levels can be improved by adding an additional biomarker of the glucose...
-
„Time in range“ (TIR) vs. Glykohämoglobin Typ A1c (HbA1c): was zählt für unsere Patienten?
The use of continuous glucose monitoring (CGM) systems and CGM-based metrics has increased massively in recent years in clinical care. However, HbA 1c ...
-
HbA1c variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes
Aims/hypothesisThe role of HbA 1c variability in the progression of diabetic kidney disease is unclear, with most studies to date performed in White...
-
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
Aims/hypothesisPrevious studies have shown that individuals with similar mean glucose levels (MG) or percentage of time in range (TIR) may have...
-
Real-world HbA1c changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes
PurposeThe purpose of this study was to evaluate patient, prescriber, and dose characteristics and evaluate changes in glycated hemoglobin (HbA 1c )...
-
Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators
IntroductionA post hoc analysis of the PIONEER 1–5 and 8 trials assessed the clinically relevant composite endpoints of HbA 1c (glycated haemoglobin)...
-
Can the level of HbA1C predict diabetic retinopathy among type II diabetic patients?
BackgroundHemoglobin A1C (HbA 1 C) test is the best care evaluation measurement due to a strong correlation between the test results and diabetic...
-
The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
Aims/hypothesisScreening programmes can detect cases of undiagnosed diabetes earlier than symptomatic or incidental diagnosis. However, the...
-
High prevalence and significant ethnic differences in actionable HbA1C after gestational diabetes mellitus in women living in Norway
BackgroundThe type 2 diabetes risk after gestational diabetes mellitus (GDM) is twice as high in South Asian compared to European women. Current...
-
First-trimester HbA1c in relation to plasma glucose concentrations in an oral glucose tolerance test at 12 to 16 weeks’ gestation—a population-based study
BackgroundEarly-onset GDM often requires pharmacological treatment and is associated with adverse perinatal outcomes, but data is insufficient...
-
-
-
-
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Aims/hypothesisThe aim of this study was to assess the dose–response effects of the subcutaneous glucagon receptor/glucagon-like peptide-1 receptor...
